Literature DB >> 22677038

Hypoxia imaging with the nitroimidazole 18F-FAZA PET tracer: a comparison with OxyLite, EPR oximetry and 19F-MRI relaxometry.

Ly-Binh-An Tran1, Anne Bol, Daniel Labar, Bénédicte Jordan, Julie Magat, Lionel Mignion, Vincent Grégoire, Bernard Gallez.   

Abstract

BACKGROUND AND
PURPOSE: (18)F-FAZA is a nitroimidazole PET tracer that can provide images of tumor hypoxia. However, it cannot provide absolute pO(2) values. To qualify (18)F-FAZA PET, we compared PET images to pO(2) measured by OxyLite, EPR oximetry and (19)F-MRI.
MATERIALS AND METHODS: Male WAG/Rij rats grafted with rhabdomyosarcoma were used. Tumor oxygenation was modified by gas breathing (air or carbogen). The same day of PET acquisition, the pO(2) was measured in the same tumor either by OxyLite probes (measurement at 10 different sites), EPR oximetry using low frequency EPR or (19)F-relaxometry using 15C5 on an 11.7T MR system.
RESULTS: There was a good correlation between the results obtained by PET and EPR (R = 0.93). In the case of OxyLite, although a weaker correlation was observed (R = 0.55), the trend for two values to agree was still related to the inverse function theoretically predicted. For the comparison of (18)F-FAZA PET and (19)F-MRI, no change in T(1) was observed.
CONCLUSIONS: A clear correlation between (18)F-FAZA PET image intensities and tumor oxygenation was demonstrated, suggesting that (18)F-FAZA PET is a promising imaging technique to guide cancer therapy.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22677038     DOI: 10.1016/j.radonc.2012.04.011

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  27 in total

1.  Standardized uptake value in high uptake area on positron emission tomography with 18F-FRP170 as a hypoxic cell tracer correlates with intratumoral oxygen pressure in glioblastoma.

Authors:  Takaaki Beppu; Kazunori Terasaki; Toshiaki Sasaki; Shunrou Fujiwara; Hideki Matsuura; Kuniaki Ogasawara; Koichiro Sera; Noriyuki Yamada; Noriyuki Uesugi; Tamotsu Sugai; Kohsuke Kudo; Makoto Sasaki; Shigeru Ehara; Ren Iwata; Yoshihiro Takai
Journal:  Mol Imaging Biol       Date:  2014-02       Impact factor: 3.488

Review 2.  Radiopharmaceuticals as probes to characterize tumour tissue.

Authors:  Israt S Alam; Mubarik A Arshad; Quang-Dé Nguyen; Eric O Aboagye
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-02-03       Impact factor: 9.236

Review 3.  A review of flux considerations for in vivo neurochemical measurements.

Authors:  David W Paul; Julie A Stenken
Journal:  Analyst       Date:  2015-06-07       Impact factor: 4.616

Review 4.  Kinetic modeling in PET imaging of hypoxia.

Authors:  Fan Li; Jesper T Joergensen; Anders E Hansen; Andreas Kjaer
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-09-06

5.  Imaging of brain oxygenation with magnetic resonance imaging: A validation with positron emission tomography in the healthy and tumoural brain.

Authors:  Samuel Valable; Aurélien Corroyer-Dulmont; Ararat Chakhoyan; Lucile Durand; Jérôme Toutain; Didier Divoux; Louisa Barré; Eric T MacKenzie; Edwige Petit; Myriam Bernaudin; Omar Touzani; Emmanuel L Barbier
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

Review 6.  Preclinical PET tracers for the evaluation of sarcomas: understanding tumor biology.

Authors:  Ian R Sigal; Ronnie Sebro
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-12-20

Review 7.  Positron emission tomography to assess hypoxia and perfusion in lung cancer.

Authors:  Eline E Verwer; Ronald Boellaard; Astrid Am van der Veldt
Journal:  World J Clin Oncol       Date:  2014-12-10

8.  Dynamic EPR Oximetry of Changes in Intracerebral Oxygen Tension During Induced Thromboembolism.

Authors:  Huagang Hou; Nadeem Khan; Sangeeta Gohain; Clifford J Eskey; Karen L Moodie; Kirk J Maurer; Harold M Swartz; Periannan Kuppusamy
Journal:  Cell Biochem Biophys       Date:  2017-04-22       Impact factor: 2.194

9.  A prospective clinical study of ¹⁸F-FAZA PET-CT hypoxia imaging in head and neck squamous cell carcinoma before and during radiation therapy.

Authors:  Stéphanie Servagi-Vernat; Sarah Differding; Francois-Xavier Hanin; Daniel Labar; Anne Bol; John A Lee; Vincent Grégoire
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-26       Impact factor: 9.236

10.  PET hypoxia imaging with FAZA: reproducibility at baseline and during fractionated radiotherapy in tumour-bearing mice.

Authors:  M Busk; L S Mortensen; M Nordsmark; J Overgaard; S Jakobsen; K V Hansen; J Theil; J F Kallehauge; F P D'Andrea; T Steiniche; M R Horsman
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-10-18       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.